Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MDK | P21741 | 4/20 | 0.53 |
| ▸ | BDNF | P23560 | 3/20 | 0.53 |
| ▸ | PTN | P21246 | 2/20 | 0.53 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.53 |
| ▸ | LGALS3 | P17931 | 4/20 | 0.47 |
| ▸ | LGALS8 | O00214 | 1/20 | 0.47 |
| ▸ | LGALS4 | P56470 | 1/20 | 0.47 |
| ▸ | CD69 | Q07108 | 1/20 | 0.45 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.41 |
| ▸ | THRB | P10828 | 1/20 | 0.41 |
| ▸ | CHIA | Q9BZP6 | 1/20 | 0.41 |
| ▸ | FGF1 | P05230 | 2/20 | 0.40 |
| ▸ | NOD2 | Q9HC29 | 1/20 | 0.40 |
| ▸ | FGF2 | P09038 | 1/20 | 0.40 |
| ▸ | VEGFA | P15692 | 1/20 | 0.40 |
| ▸ | HPSE | Q9Y251 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31556472 | 1.00 | MDK (0.53) | MDKBDNFPTNMAPK1LGALS3 | |
| SCHEMBL29459917 | 1.00 | MDK (0.53) | MDKBDNFPTNMAPK1LGALS3 | |
| SCHEMBL31067715 | 1.00 | MDK (0.53) | MDKBDNFPTNMAPK1LGALS3 | |
| SCHEMBL31067693 | 1.00 | MDK (0.53) | MDKBDNFPTNMAPK1LGALS3 | |
| SCHEMBL932879 | 1.00 | MDK (0.53) | MDKBDNFPTNMAPK1LGALS3 | |
| SCHEMBL24484198 | 1.00 | MDK (0.53) | MDKBDNFPTNMAPK1LGALS3 | |
| SCHEMBL6748051 | 1.00 | MDK (0.53) | MDKBDNFPTNMAPK1LGALS3 | |
| SCHEMBL20516492 | 1.00 | MDK (0.53) | MDKBDNFPTNMAPK1LGALS3 | |
| SCHEMBL22071113 | 1.00 | MDK (0.53) | MDKBDNFPTNMAPK1LGALS3 | |
| SCHEMBL29459916 | 1.00 | MDK (0.53) | MDKBDNFPTNMAPK1LGALS3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119925393-A | Application of unsaturated hyaluronic acid tetrasaccharide in preparation of platelet quantity increasing or platelet accumulation increasing products | 中国海洋大学 | 2025-05-06 | — | — | CN | disclosed |
| CN-119859288-A | Carbohydrate crosslinkers | 高德美控股有限公司 | 2025-04-22 | — | — | CN | disclosed |
| CN-113801904-B | Hyaluronic acid oligosaccharide composition and preparation method and application thereof | 华熙生物科技股份有限公司 | 2025-04-08 | — | — | CN | disclosed |
| US-12256737-B2 | Preparation method and application of water-soluble chlorhexidine hyaluronate antibacterial agents | JIANGNAN UNIVERSITY (CN) | 2025-03-25 | — | — | US | disclosed |
| US-20240292841-A1 | Preparation method and application of water-soluble chlorhexidine hyaluronate antibacterial agents | JIANGNAN UNIVERSITY (CN) | 2024-09-05 | — | — | US | disclosed |
| CN-118308445-A | Application of GH79 family hyaluronan lyase FeHL in production of unsaturated hyaluronan oligosaccharide | 山东大学 | 2024-07-09 | — | — | CN | disclosed |
| CN-118308446-A | Application of GH56 family hyaluronan lyase SpskHL in production of unsaturated hyaluronan oligosaccharide | 山东大学 | 2024-07-09 | — | — | CN | disclosed |
| WO-2023131355-A1 | WATER-SOLUBLE CHLORHEXIDINE ANTIBACTERIAL, PREPARATION METHOD THEREFOR AND APPLICATION THEREOF | 江南大学 | 2023-07-13 | — | — | WO | disclosed |
| CN-116004581-A | High-activity hyaluronidase mutant and application thereof in preparation of oligomeric hyaluronate | 武汉启瑞药业有限公司 | 2023-04-25 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240292841-A1 | Preparation method and application of water-soluble chlorhexidine hyaluronate antibacterial agents | CD44, TNF, MMP8 | MDK 604/4885BDNF 202/4885PTN 1806/4885 |
| US-12256737-B2 | Preparation method and application of water-soluble chlorhexidine hyaluronate antibacterial agents | CD44, TNF, MMP8 | MDK 604/4885BDNF 202/4885PTN 1806/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.